RE:RE:RE:not bad q3 , still holding $1.4 bill. cash cost of sales got slaughtered here, hence part of the steep decline, but they did still make money and cash flow was still strong.
they did not discuss any gains off Nevsun shares that they may have accumulated as part of their takeover, but i assume they must have picked up a healthy chunk and likely a double off thr costs. perhaps that is a Q4 gain?
the book value on this is some CDN$7.50 a share. they were worried in late 2017 or early 2018 that they might be a takeover target - well, if they were worried back then, i would think they going to be sweating now.
given the dividend, it looks like this $5 range could well be a good step into the stock.